Toshimitsu Tanaka
Kurume, 8300011, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Impact of chemotherapy exposure on tumor mutation burden in advanced colorectal cancer.
Journal: Scientific reports
Published: August 28, 2025
Nutritional indices are potentially important prognostic biomarkers before chemotherapy for non-specific subsets of cancer of unknown primary origin.
Journal: Molecular and clinical oncology
Published: June 06, 2025
Efficacy of third-line chemotherapy following nanoliposomal irinotecan combined with fluorouracil and folinic acid as second-line treatment for unresectable pancreatic cancer.
Journal: Frontiers in oncology
Published: May 11, 2025
Case Report: Catheter rupture of central venous port devices placed via the right internal jugular vein for chemotherapy in gastrointestinal cancer patients: a four-case series.
Journal: Frontiers in oncology
Published: April 30, 2025
A Rare Case of Primary Hepatic Undifferentiated Pleomorphic Sarcoma: Exploring Cancer-related Gene Mutations.
Journal: Internal medicine (Tokyo, Japan)
Published: November 10, 2024
Optimizing CAR-T treatment: A T2EVOLVE guide to raw and starting material selection.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 16, 2024
Efficacy of timing‑dependent infusion of nivolumab in patients with advanced gastric cancer.
Journal: Oncology letters
Published: April 03, 2024
Patient Satisfaction Survey on Portable Infusion Pumps for Colorectal Cancer Chemotherapy: Hard-Shelled or Soft-Shelled?
Journal: Patient preference and adherence
Published: March 13, 2024
Ex-vivo expanded CD34+ cell transplantation alleviates fibrotic liver injury via innate immune modulation in metabolic dysfunction-associated steatohepatitis mice.
Journal: Cytotherapy
Published: December 25, 2023
Changing from NAFLD to MASLD: Similar prognosis of unresectable extrahepatic gastrointestinal cancer under chemotherapy between NAFLD and MASLD.
Journal: Journal of hepatology
Published: December 06, 2023
Case report: A case of fulminant type 1 diabetes mellitus after COVID-19 vaccination during treatment of advanced gastric cancer: pitfall in managing immune-related adverse events.
Journal: Frontiers in oncology
Published: July 20, 2023
Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma.
Journal: Hepatology international
Published: July 20, 2023
Last Updated: 09/26/2026